发明授权
- 专利标题： Morpholinone compounds as factor IXA inhibitors
- 专利标题（中）： 吗啉酮化合物作为因子IXA抑制剂
-
申请号： US12791464申请日： 2010-06-01
-
公开(公告)号： US08987242B2公开(公告)日： 2015-03-24
- 发明人: Samuel Chackalamannil , Tin-Yau Chan , Mariappan V. Chelliah , Martin C. Clasby , Michael Dwyer , William J. Greenlee , Tomokazu Hirabayashi , Santhosh Neelamkavil , Hidemitsu Nishida , Fumihiko Saitoh , Unmesh Shah , Yan Xia
- 申请人： Samuel Chackalamannil , Tin-Yau Chan , Mariappan V. Chelliah , Martin C. Clasby , Michael Dwyer , William J. Greenlee , Tomokazu Hirabayashi , Santhosh Neelamkavil , Hidemitsu Nishida , Fumihiko Saitoh , Unmesh Shah , Yan Xia
- 申请人地址： US NJ Rahway JP Tokyo
- 专利权人： Merck Sharp & Dohme Corp.,Mochida Pharmaceuticals Co., Ltd.
- 当前专利权人： Merck Sharp & Dohme Corp.,Mochida Pharmaceuticals Co., Ltd.
- 当前专利权人地址： US NJ Rahway JP Tokyo
- 代理商 Nichole M. Beeler; Catherine D. Fitch
- 主分类号： A61K31/535
- IPC分类号： A61K31/535 ; A01N43/00 ; A61K31/33 ; C07D413/12 ; A61K31/397 ; A61K31/496 ; A61K31/5375 ; A61K31/5377 ; A61K31/54 ; A61K31/7088 ; A61K39/395 ; A61K45/06 ; C07D265/32 ; C07D413/10 ; C07D413/14 ; C07D417/10
摘要：
The present invention provides a compound of Formula (I) as described herein, or a pharmaceutically acceptable salt or a solvate thereof. The present invention also provides pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing a thromboses, embolisms, hypercoagulability or fibrotic changes.
公开/授权文献
- US20110135650A1 MORPHOLINONE COMPOUNDS AS FACTOR IXA INHIBITORS 公开/授权日：2011-06-09
信息查询
